Vivien Hébert

10PUBLICATIONS
26CO-AUTHORS
Medical mycologyAllergyMolecular medicineToxicology (incl. clinical toxicology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 27, 2026
Tocilizumab for severe and refractory mucous membrane pemphigoid.

|Mar 07, 2026
Incidence of P200 pemphigoid: A nationwide study.

Fabienne Jouen, Marion Carrette, Marie-Laure Golinski

|Jul 19, 2023
Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case series.

Vivien Hébert, Pascal Joly

|Oct 23, 2021
Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment.

Marie Petit, Marie-Laure Walet-Balieu, Damien Schapman

|Jun 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.

V Hébert, S Bastos, K Drenovska

|Oct 17, 2020
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.

W Masmoudi, M Vaillant, S Vassileva

Pageof 2

Frequent Collaborators

4 joint publications

Pascal Joly

1 joint publications

L Ferries

1 joint publications

M Alexandre

1 joint publications

C Prost-Squarcioni